abstract |
The present invention has the formula (I) suitable for the treatment of diseases associated with breton-type tyrosine kinase (BTK), wherein the groups R1, R2, R3, R4 and R5 are defined herein. Compounds, processes for making these compounds, pharmaceutical preparations containing these compounds, and methods of their use. |